← All trials
NCT04274257
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 4, 2017
- Primary completion
- May 9, 2019
- Completion date
- Nov 5, 2019
- First posted
- Feb 18, 2020
- Last posted
- Feb 18, 2020
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tokyo UniversityLead sponsor
- Japan Agency for Medical Research and DevelopmentCollaborator
- Tokyo UniversityReponsible party - principal investigator
- Tokyo UniversityOverall official - principal investigator
- Zenyaku Kogyo Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.